{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T09:28:41Z","timestamp":1780824521261,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clinbiochem.2024.110718","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T23:16:10Z","timestamp":1705792570000},"page":"110718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preparing for another Ebola Outbreak: The impact of viral inactivation methods on commonly measured biochemistry analytes in plasma and urine"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7137-9674","authenticated-orcid":false,"given":"Janet","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franceska","family":"Sevilleno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fari","family":"Rokhforooz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-968X","authenticated-orcid":false,"given":"Jennifer","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110718_b0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","article-title":"Ebola virus disease","volume":"6","author":"Jacob","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clinbiochem.2024.110718_b0010","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-pathol-052016-100506","article-title":"The pathogenesis of ebola virus disease","volume":"12","author":"Baseler","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.clinbiochem.2024.110718_b0015","unstructured":"Centers for Disease Control and Prevention, Ebola Disease, 2023. https:\/\/www.cdc.gov\/vhf\/ebola\/index.html. (Accessed July 2023)."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110718_b0020","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jalm\/jfab006","article-title":"Inactivation of blood-borne enveloped viruses with the nonionic detergent 2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethanol does not bias clinical chemistry results","volume":"6","author":"Bailey","year":"2021","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.clinbiochem.2024.110718_b0025","unstructured":"Centers for Disease Control and Prevention, Interim Guidance for Managing Patients with Suspected Viral Hemorrhagic Fever in U.S. Hospitals, 2005."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110718_b0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1128\/jcm.20.3.486-489.1984","article-title":"Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses","volume":"20","author":"Mitchell","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinbiochem.2024.110718_b0035","series-title":"Laboratory guidance: viral haemorrhagic fevers including Ebola virus disease","author":"Public Health Ontario","year":"2022"},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110718_b0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/infdis\/jix401","article-title":"Ebola virus inactivation by detergents is annulled in serum","volume":"216","author":"van Kampen","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinbiochem.2024.110718_b0045","unstructured":"World Health Organization, General Procedures for Inactivation of Potentially Infectious Samples with Ebola Virus and Other Highly Pathogenic Viral Agents, 2014."},{"key":"10.1016\/j.clinbiochem.2024.110718_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2016.11.009","article-title":"Evaluation of the inactivation effect of Triton X-100 on Ebola virus infectivity","volume":"86","author":"Colavita","year":"2017","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110718_b0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jobb.2022.08.001","article-title":"Heat inactivation of monkeypox virus","volume":"4","author":"Bat\u00e9jat","year":"2022","journal-title":"Journal of Biosafety and Biosecurity"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110718_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jobb.2020.12.001","article-title":"Heat inactivation of the severe acute respiratory syndrome coronavirus 2","volume":"3","author":"Bat\u00e9jat","year":"2021","journal-title":"Journal of Biosafety and Biosecurity"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110718_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28126","article-title":"Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: The example of SARS-CoV-2 and monkeypox virus","volume":"95","author":"Qu\u00e9rom\u00e8s","year":"2023","journal-title":"J. Med. Virol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110718_b0070","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1515\/cclm-2015-0119","article-title":"Diagnostic performances of clinical laboratory tests using Triton X-100 to reduce the biohazard associated with routine testing of Ebola virus-infected patients","volume":"53","author":"Tempestilli","year":"2015","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110718_b0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1373\/clinchem.2004.031666","article-title":"Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma","volume":"50","author":"Hersberger","year":"2004","journal-title":"Clin Chem"},{"issue":"Pt 6","key":"10.1016\/j.clinbiochem.2024.110718_b0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1258\/0004563001899997","article-title":"Effects of heating plasma at 56 degrees C for 30 min and at 60 degrees C for 60 min on routine biochemistry analytes","volume":"37","author":"Bhagat","year":"2000","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.clinbiochem.2024.110718_b0085","unstructured":"Institute for Quality Management in Healthcare, Appendix A: Chemistry Precision Goals and Allowable Performance Limits, 2021."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:00:52Z","timestamp":1757865652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":17,"alternative-id":["S0009912024000122"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110718","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preparing for another Ebola Outbreak: The impact of viral inactivation methods on commonly measured biochemistry analytes in plasma and urine","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110718"}}